Zhejiang Anglikang Pharmaceutical Co Ltd Class A Net Asset Momentum
Zhejiang Anglikang Pharmaceutical Co Ltd Class A net asset momentum. Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) recorded a net asset momentum of 3.8% as of December 2025, with net assets of CN¥1.87 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore 002940 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)
Net asset momentum of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. This chart tracks Zhejiang Anglikang Pharmaceutical Co Ltd Class A's year-over-year net asset growth across 12 annual reporting periods from 2014 to 2025. The most recent momentum reading is +3.8%, with net assets of CN¥1.87 Billion CNY as of December 2025. See Zhejiang Anglikang Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Net Asset Momentum by Year (2014–2025)
Zhejiang Anglikang Pharmaceutical Co Ltd Class A net asset momentum by year from 2014 to 2025. The table below shows the complete annual net asset history for Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025, covering 12 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Zhejiang Anglikang Pharmaceutical Co Ltd (002940) total market value.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.87 Billion | CN¥2.95 Billion | CN¥1.08 Billion | ▲ +3.8% |
| 2024 | CN¥1.80 Billion | CN¥2.97 Billion | CN¥1.18 Billion | ▼ -1.8% |
| 2023 | CN¥1.83 Billion | CN¥3.02 Billion | CN¥1.19 Billion | ▲ +11.3% |
| 2022 | CN¥1.65 Billion | CN¥2.60 Billion | CN¥949.93 Million | ▲ +11.6% |
| 2021 | CN¥1.47 Billion | CN¥2.08 Billion | CN¥608.64 Million | ▲ +7.0% |
| 2020 | CN¥1.38 Billion | CN¥1.94 Billion | CN¥562.78 Million | ▲ +35.6% |
| 2019 | CN¥1.02 Billion | CN¥1.38 Billion | CN¥368.51 Million | ▲ +4.7% |
| 2018 | CN¥970.93 Million | CN¥1.47 Billion | CN¥499.27 Million | ▲ +146.2% |
| 2017 | CN¥394.37 Million | CN¥906.78 Million | CN¥512.41 Million | ▲ +20.4% |
| 2016 | CN¥327.43 Million | CN¥727.99 Million | CN¥400.56 Million | ▲ +23.9% |
| 2015 | CN¥264.20 Million | CN¥799.83 Million | CN¥535.63 Million | ▲ +21.7% |
| 2014 | CN¥217.08 Million | CN¥731.44 Million | CN¥514.36 Million | — |